Morgan Stanley Rates UnitedHealth (UNH) buy, $468 Price Target

Morgan Stanley maintains its buy rating on UnitedHealth Group, setting a $468 price target, a 12.60% upside from the current price.

By EarningsIQ Research Desk · Published Jun 30, 2026, 10:01 AM EDT · Updated Jul 1, 2026, 3:01 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Morgan Stanley rated UnitedHealth Group Incorporated ($UNH) "buy" with a $468 price target on June 30, 2026.

Since the rating, $UNH is up 3.0% after 1 week, up 1.4% after 1 month and down 2.8% to date (from the $413.09 close on Jun 30, 2026).

UNH UnitedHealth Group Incorporated

$401.43 +21.69% year to date

Daily close · Oct 16, 2026

Key Points

Morgan Stanley reiterated its buy rating for UnitedHealth Group with a price target of $468 on June 30, 2026.
Morgan Stanley's $468 price target implies 12.60% upside from UnitedHealth Group Incorporated's ($UNH) current $415.63 share price.
Shares of NYSE:UNH traded at $419.82 on Tuesday, with a market cap of $388.6 billion and a P/E ratio of 32.3.
Insiders at UnitedHealth Group, including CEO Stephen Hemsley, recently bought shares, and multiple analysts maintain a buy rating.

Get $UNH trade alerts by text

We text you when insiders, Congress or big funds trade $UNH. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated UnitedHealth Group Incorporated alert may contain errors. Disclosures

Morgan Stanley has reiterated its buy rating on UnitedHealth Group Incorporated (NYSE:UNH) with a price target of $468. This affirmation came on June 30, 2026, as Erin Wright from Morgan Stanley maintained confidence in the healthcare giant's performance.

Analyst rating track record

Morgan Stanley vs. the S&P 500

YTD return +40.06% hypothetical

All-time return +36.41% S&P 500 +34.48%

vs. S&P 500 +1.93% ahead of the index

Hypothetical returns from Morgan Stanley's disclosed trades, not real profit or advice. How we model this.

Other Institutional Activity in UnitedHealth Group

BlackRock, Inc. reduced its holdings in UnitedHealth Group by 1,276,021 shares, bringing its total to 73,467,531 shares valued at about $19.88 billion. Meanwhile, Vanguard Capital Management LLC opened a new position with 58,870,777 shares worth approximately $15.93 billion. State Street Corp added 100,016 shares, ending with 45,332,186 shares valued at around $12.27 billion. Capital World Investors increased its stake by 5,192,373 shares to 27,783,415 shares, valued at roughly $7.52 billion. Geode Capital Management, LLC added 977,105 shares, reaching a total of 22,768,695 shares worth about $6.14 billion.

UnitedHealth Group Incorporated Stock Up 5.1%

Shares of NYSE:UNH traded near $419.82 on Tuesday. UnitedHealth Group has a market cap of approximately $388.6 billion, a P/E ratio of 32.3, and a beta of 0.65, indicating lower volatility compared to the market. The stock's 52-week range is between $234.60 and $427.93, with a 50-day moving average of $382.92 and a 200-day moving average of $335.87.

12-month forecast

$UNH price target

UnitedHealth Group Incorporated daily closes and this analyst's $468 target. Not advice.

Recent Earnings

UnitedHealth Group reported revenue of about $449.71 billion, with a modest growth rate of 2%. The company achieved an EPS of $13.26, a net margin of 2.68%, and a return on equity of 12.18%. Investors can look forward to the next earnings release on July 16, 2026.

Dividend

UnitedHealth Group offers an annual dividend rate of $9.28, yielding 2.17%. The company's dividend payout ratio stands at 66.57%, reflecting a commitment to returning value to shareholders.

Insider Buying and Selling at UnitedHealth Group Incorporated

On June 23, 2026, several insiders, including CEO Stephen Hemsley, purchased shares of UnitedHealth Group. Hemsley acquired 46 shares, while other executives like EVP & Chief Legal Officer Christopher Zaetta bought 61 shares. These transactions were not part of any pre-planned trading programs.

Analysts Set New Price Targets

On June 30, 2026, Morgan Stanley maintained its buy rating on UnitedHealth Group with a $468 price target. B of A Securities also maintained a buy rating with a target of $475 on June 24, 2026. Meanwhile, on June 17, 2026, Leerink Partners reiterated a buy rating, setting a target of $462. The consensus among 26 analysts is a buy recommendation, with an average target price of $411.31.

About UnitedHealth Group

UnitedHealth Group Incorporated is a leading healthcare company based in Eden Prairie, Minnesota. It operates through segments such as Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, offering a wide range of health services. The company provides care delivery, pharmacy care services, software solutions, and consumer-oriented health benefit plans. Founded in 1974, UnitedHealth Group serves clients both in the United States and internationally, employing around 390,000 people.

Bottom Line

Morgan Stanley's reiterated buy rating and $468 price target reflect confidence in UnitedHealth Group's prospects. The company's substantial market cap and consistent earnings growth make it a key player in the healthcare sector. As insiders continue to buy shares and analysts maintain positive ratings, investors will be watching closely for the upcoming earnings report.